Q5SV42
Gene name |
Serpinb1c |
Protein name |
Leukocyte elastase inhibitor C |
Names |
Serine protease inhibitor EIC, Serpin B1c |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:380839 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5SV42
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5SV42-F1 | Predicted | AlphaFoldDB |
46 variants for Q5SV42
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs260973677 | 12 | A>V | No | EVA | |
| rs254473750 | 16 | F>S | No | EVA | |
| rs3389269233 | 23 | N>D | No | EVA | |
| rs3389250913 | 56 | K>M | No | EVA | |
| rs3389234360 | 57 | T>I | No | EVA | |
| rs584834332 | 69 | Q>H | No | EVA | |
| rs579062123 | 69 | Q>R | No | EVA | |
| rs579247941 | 74 | T>N | No | EVA | |
| rs3389206207 | 79 | K>R* | No | EVA | |
| rs3389274370 | 80 | R>C | No | EVA | |
| rs585467803 | 104 | Y>F | No | EVA | |
| rs221449344 | 108 | I>T | No | EVA | |
| rs255790095 | 111 | T>M | No | EVA | |
| rs238799847 | 113 | S>G | No | EVA | |
| rs213476446 | 118 | L>P | No | EVA | |
| rs3404043305 | 142 | E>V | No | EVA | |
| rs29899459 | 148 | F>L | No | EVA | |
| rs3389276122 | 150 | V>SDG* | No | EVA | |
| rs3389274342 | 151 | G>S | No | EVA | |
| rs3389206162 | 153 | V>G | No | EVA | |
| rs3389250941 | 154 | D>G | No | EVA | |
| rs3389250929 | 156 | M>L | No | EVA | |
| rs240273514 | 157 | T>I | No | EVA | |
| rs3389277153 | 163 | N>S | No | EVA | |
| rs3389288802 | 165 | T>I | No | EVA | |
| rs3404093533 | 170 | M>I | No | EVA | |
| rs29899460 | 177 | A>T | No | EVA | |
| rs3404093613 | 178 | R>W | No | EVA | |
| rs235209150 | 186 | R>Q | No | EVA | |
| rs257856305 | 206 | F>L | No | EVA | |
| rs231288187 | 221 | Y>F | No | EVA | |
| rs215788320 | 224 | G>E | No | EVA | |
| rs245186523 | 227 | S>N | No | EVA | |
| rs29899461 | 228 | M>T | No | EVA | |
| rs259224104 | 240 | T>S | No | EVA | |
| rs3389277182 | 262 | Q>R | No | EVA | |
| rs29900332 | 278 | S>N | No | EVA | |
| rs3389243548 | 291 | Q>H | No | EVA | |
| rs3389234322 | 294 | F>L | No | EVA | |
| rs3389274361 | 294 | F>L | No | EVA | |
| rs261470406 | 312 | I>V | No | EVA | |
| rs235575268 | 315 | I>T | No | EVA | |
| rs29900333 | 339 | V>D | No | EVA | |
| rs3389288810 | 349 | T>A | No | EVA | |
| rs3389283636 | 357 | F>S | No | EVA | |
| rs29901235 | 367 | L>F | No | EVA |
No associated diseases with Q5SV42
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasmic ribonucleoprotein granule | A ribonucleoprotein granule located in the cytoplasm. |
| extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| peptidase inhibitor activity | Binds to and stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of endopeptidase activity | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| negative regulation of interleukin-1 beta production | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production. |
| type B pancreatic cell proliferation | The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin. |
36 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q9N2I2 | SERPINA5 | Plasma serine protease inhibitor | Bos taurus (Bovine) | PR |
| P41361 | SERPINC1 | Antithrombin-III | Bos taurus (Bovine) | PR |
| A6QPQ2 | SERPINA3-8 | Serpin A3-8 | Bos taurus (Bovine) | PR |
| A2I7N1 | SERPINA3-5 | Serpin A3-5 | Bos taurus (Bovine) | PR |
| P13909 | SERPINE1 | Plasminogen activator inhibitor 1 | Bos taurus (Bovine) | PR |
| Q9TTE1 | SERPINA3-1 | Serpin A3-1 | Bos taurus (Bovine) | PR |
| Q1JPB0 | SERPINB1 | Leukocyte elastase inhibitor | Bos taurus (Bovine) | PR |
| O73790 | SERPINB10 | Heterochromatin-associated protein MENT | Gallus gallus (Chicken) | PR |
| P05619 | SERPINB1 | Leukocyte elastase inhibitor | Equus caballus (Horse) | PR |
| P05121 | SERPINE1 | Plasminogen activator inhibitor 1 | Homo sapiens (Human) | PR |
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Homo sapiens (Human) | PR |
| P05155 | SERPING1 | Plasma protease C1 inhibitor | Homo sapiens (Human) | PR |
| P08697 | SERPINF2 | Alpha-2-antiplasmin | Homo sapiens (Human) | PR |
| Q86WD7 | SERPINA9 | Serpin A9 | Homo sapiens (Human) | PR |
| P01008 | SERPINC1 | Antithrombin-III | Homo sapiens (Human) | PR |
| P07093 | SERPINE2 | Glia-derived nexin | Homo sapiens (Human) | PR |
| Q96P15 | SERPINB11 | Serpin B11 | Homo sapiens (Human) | PR |
| P01011 | SERPINA3 | Alpha-1-antichymotrypsin | Homo sapiens (Human) | PR |
| P12388 | Serpinb2 | Plasminogen activator inhibitor 2, macrophage | Mus musculus (Mouse) | PR |
| P32261 | Serpinc1 | Antithrombin-III | Mus musculus (Mouse) | PR |
| Q07235 | Serpine2 | Glia-derived nexin | Mus musculus (Mouse) | PR |
| Q80X76 | Serpina3f | Serine protease inhibitor A3F | Mus musculus (Mouse) | PR |
| Q8BYY9 | Serpina3b | Serine protease inhibitor A3B | Mus musculus (Mouse) | PR |
| Q9D154 | Serpinb1a | Leukocyte elastase inhibitor A | Mus musculus (Mouse) | PR |
| Q9JK88 | Serpini2 | Serpin I2 | Mus musculus (Mouse) | PR |
| Q8CDC0 | Serpinb13 | Serpin B13 | Mus musculus (Mouse) | PR |
| P22777 | Serpine1 | Plasminogen activator inhibitor 1 | Mus musculus (Mouse) | PR |
| Q5I2A0 | Serpina3g | Serine protease inhibitor A3G | Mus musculus (Mouse) | PR |
| P29524 | Serpinb2 | Plasminogen activator inhibitor 2 type A | Rattus norvegicus (Rat) | PR |
| Q6P734 | Serping1 | Plasma protease C1 inhibitor | Rattus norvegicus (Rat) | PR |
| P05545 | Serpina3k | Serine protease inhibitor A3K | Rattus norvegicus (Rat) | PR |
| P07092 | Serpine2 | Glia-derived nexin | Rattus norvegicus (Rat) | PR |
| Q62975 | Serpina10 | Protein Z-dependent protease inhibitor | Rattus norvegicus (Rat) | PR |
| O48706 | At2g26390 | Serpin-Z3 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9M1T7 | At3g45220 | Serpin-Z4 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9ZQR6 | At2g14540 | Serpin-Z2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGQLSSANNL | FALELFHTLN | ESNPTGNTIF | SPVSISSALA | MVYLGARGST | AAQLSKTLHF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| DSAEDIHSQF | QSLTAEVSKR | GASHTLKLAN | RLYGEKTYNF | LPEYLASIQK | TYSADLALVD |
| 130 | 140 | 150 | 160 | 170 | 180 |
| FQHASEDARK | EINQWVKGQT | EEKIQELFAV | GVVDSMTKLV | LVNATYFKGM | WQKKFMARDT |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TDAPFRLSKK | VTKTVKMMYL | KNNLPFGYIP | DLKCKVLEMP | YQGGELSMVI | LLPEDIEDET |
| 250 | 260 | 270 | 280 | 290 | 300 |
| TGLEEIEKQL | TLEKLQECEN | LQNIDVCVKL | PKFKMEESYI | LNSNLGQLGV | QDLFSSSKAD |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LSGMSGSRDL | FISKIVHKSY | VEVNEEGTET | DAAMPGTVVG | CCLMPMEFTV | DHPFLFFIRH |
| 370 | |||||
| NPTAHVLFLG | RVCSP |